Results 161 to 170 of about 5,996,360 (285)

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer.

New England Journal of Medicine, 2015
C. Sweeney, Yu‐Hui Chen, M. Carducci, Glenn Liu, D. Jarrard, M. Eisenberger, Y. Wong, N. Hahn, M. Kohli, M. Cooney, R. Dreicer, N. Vogelzang, J. Picus, D. Shevrin, M. Hussain, Jorge A. Garcia, R. DiPaola   +16 more
semanticscholar   +1 more source

Real‐Time Digital Micromotor Tracking‐Enabled Ultrasensitive Immunoassay

Advanced Science, EarlyView.
An AI‐facilitated real‐time digital micromotor tracking‐enabled immunoassay is developed, which leverages a self‐developed multi‐microparticle tracking system to monitor micromotor motion trajectories in a real‐time manner for digital protein analysis.
Jingjing Shi, Zuhua Yu, Hui Tian, Wenjiao Fan, Yuanyuan Sun, Wei Ren, Chenghui Liu   +6 more
wiley   +1 more source

Immune Checkpoint Inhibitors and Immunomodulators for Cancer Immunotherapy: Insights Into Resistance and Therapeutic Strategies

Advanced Science, EarlyView.
The schematic diagram illustrates the roles of novel immune checkpoints, immunomodulatory factors, cell death and multimodal technologies in cancer immunotherapy. Abstract Cancer immunotherapy has redefined cancer treatment. However, the molecular and cellular basis of immune evasion and therapeutic resistance remains incompletely understood.
Fangquan Chen, Yang Yu, Xiutao Cai, Junhao Lin, Ruirui Liang, Rui Kang, Daolin Tang, Jiao Liu   +7 more
wiley   +1 more source

Optimising Radiotherapy for Prostate Cancer: Comparison of Treatment Schedules and Toxicities. [PDF]

Cureus
Asha K, Js L, Narayanan Ms S, Tm H, Srinivas S, John C.   +5 more
europepmc   +1 more source

AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.

New England Journal of Medicine, 2014
E. Antonarakis, Changxue Lu, Hao Wang, Brandon S. Luber, M. Nakazawa, J. Roeser, Yan Chen, Tabrez A Mohammad, Yidong Chen, Helen L. Fedor, T. Lotan, Qizhi Zheng, A. D. De Marzo, J. Isaacs, W. Isaacs, R. Nadal, C. Paller, S. Denmeade, M. Carducci, M. Eisenberger, Jun Luo   +20 more
semanticscholar   +1 more source

Novel Vascular‐Adaptive Liquid Metal Microspheres Enable Visualized Arterial Embolization Therapy

Advanced Science, EarlyView.
We present drug‐loaded liquid metal microspheres (X‐MEN) as a novel agent for image‐guided arterial embolization. With inherent radiopacity and superior deformability, X‐MEN enables real‐time monitoring and conforms tightly to irregular vessels. This approach ensures precise, long‐lasting embolization without recanalization, addressing critical ...
Chenyu Shen, Junge Chen, Gang Zhang, Zhusheng Liu, Yichen Wan, Lei Lei, Weiyan Ren, Yanyu Zhao, Bozhang Xia, Zhiqiang Yi, Jinjin Wang, Jingwang Gao, Gen Mu, Xing‐Jie Liang, Zhijun Wang   +14 more
wiley   +1 more source

Combined prostate cancer vaccine plus immune checkpoint inhibition synergizes to eliminate prostate cancer. [PDF]

iScience
Carreno-Galeano G, Dubey S, Iczkowski KA, Van Veldhuizen P, Anele UA, Messer JC, Ankem MK, Karan D.   +7 more
europepmc   +1 more source

Beyond Extracellular Vesicle (EV) Hype: Practical Solutions and Remaining Hurdles in EV Research, Manufacturing, and Clinical Translation

Advanced Science, EarlyView.
ABSTRACT Extracellular vesicles (EVs) are nanoscale mediators of intercellular communication with diverse molecular cargoes that reflect their cell of origin. Advances in isolation, detection, and single‐particle analytics have revealed increasing molecular and functional heterogeneity, while exposing limitations in how EV identity and activity are ...
David J. Lundy, Zoe L. Chau, Sheng‐You Chen, Nanami Fujisawa, John J. Hill, Barnett M. Hsu, Joanne K. Liu, Karol W. Mai, James J. Lai   +8 more
wiley   +1 more source

The future of prostate cancer screening. [PDF]

EClinicalMedicine
eClinicalMedicine.
europepmc   +1 more source

Leveraging Artificial Intelligence and Large Language Models for Cancer Immunotherapy

Advanced Science, EarlyView.
Cancer immunotherapy faces challenges in predicting treatment responses and understanding resistance mechanisms. Artificial intelligence (AI) and machine learning (ML) offer powerful solutions for cancer immunotherapy in patient stratification, biomarker discovery, treatment strategy optimization, and foundation model development.
Xinchao Wu, Mengtao Sun, Lusheng Li, Jieqiong Wang, Shibiao Wan   +4 more
wiley   +1 more source